Matthew Walls joined biotechnology firm Epistem as CEO in February 2007. The Manchester, UK-based firm focuses on stem cell technologies for use in therapeutic and biomarker applications. Before joining EpiStem, Mr Walls headed data management firm Oxford BioSignals, and has also worked for chemical company ICI and pharmaceutical giant AstraZeneca
Clinica: What will be the next big game-changer in the field of stem cell science?
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?